Several CpG sites in the APOE region are differentially methylated in AD cases compared to controls, and distinct methylation patterns have been observed between persons with the ε3/ε3 and ε3/ε4 genotypes [11]. The gene discussed is APOE; the disease is Alzheimer disease.